NCT06625307CompletedPhase 1
A research study on the effects of NNC0537-1482 in healthy individuals when injected under the skin.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Oct 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- First submitted
- 9 Aug 2024
- Start date
- 1 Oct 2024
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Heart failure
- EU CT number
- 2024-514431-18-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 56
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pharmaceutical Research Associates Group B.V. Coordinator of this site? Confirm its status | Groningen | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.